Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cardiovascular Systems, Inc. logo — company profile

Cardiovascular Systems, Inc.

Founded 1989 United States St. Paul, United States 343 employees Post-IPO Debt Total: $98.00M Biotechnology, Health Care +1

General Information

Company Name Cardiovascular Systems, Inc.
Founded Year 1989
Location United States St. Paul, United States
Founders / Decision Makers
Team member Team member Team member
Employees 343
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Cardiovascular Systems, Inc.. To contact Cardiovascular Systems, Inc., visit csi360.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cardiovascular Systems, Inc. compare?

A PDF of Cardiovascular Systems, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cardiovascular Systems, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cardiovascular Systems, Inc.

Cardiovascular Systems (CSI) is dedicated to providing innovative solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). Founded in 1989 in the United States, their primary focus is on helping physicians overcome challenging disease states, including arterial calcium, for those suffering from PAD and Complex PCI. CSI emphasizes clinical rigor, constant innovation, and a commitment to setting the standard in safe, effective, and affordable medical devices that enhance patient outcomes. The company upholds Core Values of accountability, integrity, excellence, courage, velocity, and community, creating an invigorating work environment for its employees. It is important to note that CSI is committed to providing equal employment opportunities (EEO) and reasonable accommodations for individuals with disabilities, aligning with their value of community. Their vision is encapsulated in their mission of 'Saving Limbs. Saving Lives. Every Day.' The company received a $2.00M Post-IPO Debt investment on 12 March 2013. For more information, visit www.CSI360.com and connect with them on Twitter and Facebook. For safety information, refer to https:\/\/csi360.com\/indications-statements-important-safety-and-risk-information\/.

Business keywords: vascular disease, peripheral artery disease, coronary artery disease, arterial calcium, clinical innovation, patient outcomes, equal employment opportunity, cardiovascular treatment, work environment, core values, safety information, EEO policy, Clinical rigor

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $2.00M -
12 Mar 2013
Post IPO Debt $2.50M -
22 Feb 2013
Post IPO Debt $13.50M -
12 Feb 2013
Post IPO Debt $1.00M -
29 Aug 2011
Post IPO Debt $500.00K -
09 Aug 2011
Post IPO Debt $7.46M -
01 Jul 2011
Post IPO Debt $40.12K -
02 Jun 2011
Post IPO Debt $500.00K -
26 Jan 2011
Post IPO Debt $1.50M -
13 Dec 2010
Post IPO Debt $29.00M 2
Partners for Growth
Partners for Growth, Silicon Valley Bank
20 Apr 2010

View All 12 Funding Rounds

Cardiovascular Systems, Inc. Alternatives & Competitors

View All Alternatives
Cardiovascular Systems, Inc. vs
Cagent Vascular
Cagent Vascular United States

Restoring Blood Flow. Restoring Life. Serranator: Serrate & Inflate

Series C
54 employees
Health Care, Medical Devices
Compare Cardiovascular Systems, Inc. vs Cagent Vascular
Cardiovascular Systems, Inc. vs
Roxwood Medical
Roxwood Medical

Innovative solutions for advanced cardiovascular specialty catheters in Interventional Cardiology, E...

Venture round
Health Care, Medical Devices
Compare Cardiovascular Systems, Inc. vs Roxwood Medical
Cardiovascular Systems, Inc. vs
Reven Pharmaceuticals
Reven Pharmaceuticals United States

Diligently pursuing scientific innovation to exponentially improve health and well-being.

Series D
14 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is committed to providing innovative solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). Our primary focus is helping physicians conquer even the most difficult disease states, including the challenge of arteri...
Cardiovascular Systems, Inc. was founded in 1989.
Cardiovascular Systems, Inc. is headquartered in St. Paul, United States.
Cardiovascular Systems, Inc. operates in Biotechnology, Health Care and Medical Devices. Its work centres on vascular disease, peripheral artery disease, coronary artery disease and arterial calcium.
Cardiovascular Systems, Inc. has approximately 343 employees.
Cardiovascular Systems, Inc. has completed 12 funding rounds, raising a total of $98.00M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Cardiovascular Systems, Inc. include Cagent Vascular, Roxwood Medical, Reven Pharmaceuticals, Biomedix, Sonosemi Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiovascular Systems, Inc. and Cagent Vascular are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cardiovascular Systems, Inc., https://bouncewatch.com/company/cardiovascular-systems, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout